15q24 Microdeletion
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
Haploinsufficiency of MeCP2-interacting transcriptional co-repressor SIN3A causes mild intellectual disability by affecting the development of cortical integrity.
|
27399968 |
2016 |
Abnormality of cardiovascular system morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the outer ear
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the proximal phalanx of the thumb
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the thorax
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the voice
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Agenesis of corpus callosum
|
0.300 |
Biomarker
|
disease |
CTD_human |
Haploinsufficiency of MeCP2-interacting transcriptional co-repressor SIN3A causes mild intellectual disability by affecting the development of cortical integrity.
|
27399968 |
2016 |
Aggressive behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Amnesia
|
0.010 |
Biomarker
|
disease |
BEFREE |
This study examines the role of co-repressor SIN3A in scopolamine-induced amnesia through epigenetic changes in the hippocampus.
|
29494759 |
2018 |
Anisocoria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Anteverted nostril
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Aqueductal Stenosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Haploinsufficiency of MeCP2-interacting transcriptional co-repressor SIN3A causes mild intellectual disability by affecting the development of cortical integrity.
|
27399968 |
2016 |
Arachnodactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Attention deficit hyperactivity disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Autism Spectrum Disorders
|
0.310 |
Biomarker
|
disease |
BEFREE |
Here we identified dominant mutations in the gene encoding the transcriptional repressor and MeCP2 interactor switch-insensitive 3 family member A (SIN3A; chromosome 15q24.2) in individuals who, in addition to mild intellectual disability and ASD, share striking features, including facial dysmorphisms, microcephaly and short stature.
|
27399968 |
2016 |
Autism Spectrum Disorders
|
0.310 |
Biomarker
|
disease |
CTD_human |
Here we identified dominant mutations in the gene encoding the transcriptional repressor and MeCP2 interactor switch-insensitive 3 family member A (SIN3A; chromosome 15q24.2) in individuals who, in addition to mild intellectual disability and ASD, share striking features, including facial dysmorphisms, microcephaly and short stature.
|
27399968 |
2016 |
AUTISM, SUSCEPTIBILITY TO, 15
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Haploinsufficiency of MeCP2-interacting transcriptional co-repressor SIN3A causes mild intellectual disability by affecting the development of cortical integrity.
|
27399968 |
2016 |
Autistic behavior
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Novel SIN3A mutation identified in a Japanese patient with Witteveen-Kolk syndrome.
|
30267900 |
2019 |
Autistic Disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Azoospermia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This study suggests a lack of association of SIN3A gene sequence variants with azoospermia caused by SCOS in humans.
|
25395209 |
2015 |
Bilateral single transverse palmar creases
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Brachydactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Breast Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Our data indicate that LSD1 is a functional alternative subunit of the SIN3A/HDAC complex, providing a molecular basis for the interplay of histone demethylation and deacetylation in chromatin remodelling, and suggest that the LSD1/SIN3A/HDAC complex could be a target for breast cancer therapeutic strategies.
|
29741645 |
2018 |
Breast Carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Loss of Sin3A inhibited breast cancer cell growth by increasing apoptosis without affecting cell cycle progression.
|
20920219 |
2010 |
Breast Carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Additionally, we analyzed microarray data sets to identify correlations of SIN3A and SIN3B expression with survival in patients with breast cancer.
|
27780928 |
2016 |